InsiderClue
Insiders · Profile

King Rachel K.

Director at NOVAVAX · President, CEO at CRESCENT BIOPHARMA. Filing since 27 Mar 2019. CIK 0001589712

NVAX NOVAVAX INC Director · 4 trades CBIO CRESCENT BIOPHARMA, INC. President, CEO · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
NVAX NOVAVAX INC
13 Dec 2024
Director
Sold at will
4,150
$37.44K
21.9%
NVAX NOVAVAX INC
19 May 2021
Director
Bought
700
$97.75K
33.3%
CBIO CRESCENT BIOPHARMA, INC.
28 Dec 2020
President, CEO
Sold, plan not stated
84,176
$329.13K
19.1%
NVAX NOVAVAX INC
27 Mar 2019
Director
Bought
44,000
$23.31K
opened
NVAX NOVAVAX INC
27 Mar 2019
Director
Bought
42,000
$22.25K
opened
5 decisions on file.